«Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI with or Without Bevacizumab-awwb for Treatment-naïve Subjects with Metastatic Colorectal Cancer with KRAS p. G12C Mutation»

ΕΝΕΡΓΟ RECRUITMENT Έναρξη Μελέτης: Νοε-24 Λήξη Μελέτης: Νοε-30